Evaluation of liver toxicity using Child-Pugh, MELD, and MELD-Na following stereotactic body radiation therapy (SBRT) of hepatocellular carcinomas.

Authors

null

Louis Lu

Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI

Louis Lu , Eman ElAlfy , Daniel Wahl , Matthew H. Stenmark , Theodore Steven Lawrence , Mary Uan-Sian Feng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 365)

DOI

10.1200/jco.2015.33.3_suppl.365

Abstract #

365

Poster Bd #

C34

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Liver toxicity following reirradiation and multiple-target SBRT for primary hepatocellular carcinoma.

Liver toxicity following reirradiation and multiple-target SBRT for primary hepatocellular carcinoma.

First Author: Jacob Hall

First Author: Alexander V. Kirichenko

Poster

2020 Gastrointestinal Cancers Symposium

Clinical outcomes of hepatocellular carcinoma patients with Child-Pugh class B treated with stereotactic body radiation therapy.

Clinical outcomes of hepatocellular carcinoma patients with Child-Pugh class B treated with stereotactic body radiation therapy.

First Author: J Richelcyn Baclay

Poster

2015 Gastrointestinal Cancers Symposium

Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC).

Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC).

First Author: Dimitrios Ziogas